Últimos artigos pelo autor

E Havrdová

19 artigos encontrados

Multiple sclerosis (Houndmills, Basingstoke, England)
11/08/2009
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis. (E Havrdová)
04/05/2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. (E Havrdová)
Lancet
30/10/2008
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. (E Havrdová)
29/07/2008
Epidermal innervation in type 1 diabetic patients: a 2.5-year prospective study after simultaneous pancreas/kidney transplantation. (E Havrdová)
Lancet
23/06/2008
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. (E Havrdová)
Journal of neurology, neurosurgery, and psychiatry
17/03/2008
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. (E Havrdová)
Neurology
02/10/2007
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. (E Havrdová)
Journal of neurology
06/08/2007
Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report. (E Havrdová)
Neurology
24/04/2007
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. (E Havrdová)
Neurology
17/04/2007
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. (E Havrdová)

Artigos de outros especialidades:

Cirurgia Maxilofacial, Farmacologia Clinica, Nefrologia, Medicina preventiva e social, Bioquimica clinica, Hematologia, Oncologia, Reumatologia, Cirurgia cardiovascular, Neurofisiologia Clinica, Pediatria, Dermatologia